EE05219B1 - Amkomtsiin, meetod selle valmistamiseks, kasutamine ravimina ja seda sisaldav farmatseutiline kompositsioon - Google Patents

Amkomtsiin, meetod selle valmistamiseks, kasutamine ravimina ja seda sisaldav farmatseutiline kompositsioon

Info

Publication number
EE05219B1
EE05219B1 EEP200200280A EEP200200280A EE05219B1 EE 05219 B1 EE05219 B1 EE 05219B1 EE P200200280 A EEP200200280 A EE P200200280A EE P200200280 A EEP200200280 A EE P200200280A EE 05219 B1 EE05219 B1 EE 05219B1
Authority
EE
Estonia
Prior art keywords
amcomine
medicament
preparation
pharmaceutical composition
composition containing
Prior art date
Application number
EEP200200280A
Other languages
English (en)
Estonian (et)
Inventor
Hopmann Cordula
Kurz Michael
Decker Heinrich
Le Beller Dominique
Aszodi Jozsef
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200280A publication Critical patent/EE200200280A/xx
Publication of EE05219B1 publication Critical patent/EE05219B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
EEP200200280A 1999-12-08 2000-11-25 Amkomtsiin, meetod selle valmistamiseks, kasutamine ravimina ja seda sisaldav farmatseutiline kompositsioon EE05219B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99124456A EP1106604A1 (en) 1999-12-08 1999-12-08 Amycomycin, a process for its production and its use as a pharmaceutical
PCT/EP2000/011752 WO2001042210A1 (en) 1999-12-08 2000-11-25 Amycomycin, a process for its production and its use as a pharmaceutical

Publications (2)

Publication Number Publication Date
EE200200280A EE200200280A (et) 2003-06-16
EE05219B1 true EE05219B1 (et) 2009-10-15

Family

ID=8239554

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200280A EE05219B1 (et) 1999-12-08 2000-11-25 Amkomtsiin, meetod selle valmistamiseks, kasutamine ravimina ja seda sisaldav farmatseutiline kompositsioon

Country Status (28)

Country Link
US (1) US6642391B2 (no)
EP (2) EP1106604A1 (no)
JP (1) JP4750993B2 (no)
KR (1) KR100728514B1 (no)
CN (1) CN1217929C (no)
AT (1) ATE298744T1 (no)
AU (1) AU781398B2 (no)
BR (1) BR0016223A (no)
CA (1) CA2393518C (no)
CZ (1) CZ294370B6 (no)
DE (1) DE60021109T2 (no)
DK (1) DK1237866T3 (no)
EE (1) EE05219B1 (no)
ES (1) ES2243332T3 (no)
HK (1) HK1048998A1 (no)
HR (1) HRP20020497B1 (no)
HU (1) HU225194B1 (no)
IL (2) IL149904A0 (no)
ME (1) MEP28508A (no)
NO (1) NO322565B1 (no)
PL (1) PL201809B1 (no)
PT (1) PT1237866E (no)
RS (1) RS50288B (no)
RU (1) RU2261916C2 (no)
SI (1) SI1237866T1 (no)
SK (1) SK286776B6 (no)
WO (1) WO2001042210A1 (no)
ZA (1) ZA200204420B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8700513D0 (en) * 1987-01-09 1987-02-11 Pfizer Ltd Antibiotics produced by fermentation
CA2016382A1 (en) * 1989-05-12 1990-11-12 Marvin M. Hoehn A59770 antibiotics
JPH05163289A (ja) * 1991-08-27 1993-06-29 Microbial Chem Res Found 新規な免疫抑制物質、ｍｉ７１０−５１ｆ６物質およびその製造法
JPH05286990A (ja) * 1992-04-08 1993-11-02 Meiji Seika Kaisha Ltd 新規マクロライド抗生物質および微生物変換を利用したマクロライド抗生物質の製造法
JP3107455B2 (ja) * 1992-05-08 2000-11-06 財団法人微生物化学研究会 新規抗生物質ｍｉ４８１−４２ｆ４−ａ及びその製造方法
JPH05317068A (ja) * 1992-05-14 1993-12-03 Kaiyo Bio Technol Kenkyusho:Kk 抗生物質マグネシジンの一成分の選択的製造法
JPH0733736A (ja) * 1993-07-26 1995-02-03 Microbial Chem Res Found 新規抗生物質アジセマイシンｂおよびその製造方法
JPH09157266A (ja) * 1995-12-04 1997-06-17 Microbial Chem Res Found 新規抗生物質エポキシキノマイシンａおよびｂとその製造法
EP0816539A1 (de) 1996-07-05 1998-01-07 Maschinenfabrik Rieter Ag Verfahren und Vorrichtung zur Produktionssteuerung an einer Karde
JPH1045738A (ja) * 1996-07-29 1998-02-17 Microbial Chem Res Found 抗生物質エポキシキノマイシンｃおよびｄとその製造法ならびに抗リウマチ剤
JPH10114777A (ja) * 1996-10-09 1998-05-06 Microbial Chem Res Found 抗生物質スピロキシマイシンとその製造法

Also Published As

Publication number Publication date
RU2261916C2 (ru) 2005-10-10
WO2001042210A1 (en) 2001-06-14
EE200200280A (et) 2003-06-16
EP1237866B1 (en) 2005-06-29
NO322565B1 (no) 2006-10-23
CZ294370B6 (cs) 2004-12-15
CA2393518C (en) 2009-01-20
IL149904A0 (en) 2002-11-10
JP4750993B2 (ja) 2011-08-17
DK1237866T3 (da) 2005-10-10
ME00182B (me) 2010-10-10
PL355627A1 (en) 2004-05-04
KR100728514B1 (ko) 2007-06-15
HUP0203593A3 (en) 2003-12-29
RU2002118116A (ru) 2004-02-27
EP1106604A1 (en) 2001-06-13
PL201809B1 (pl) 2009-05-29
PT1237866E (pt) 2005-10-31
AU2001901A (en) 2001-06-18
ATE298744T1 (de) 2005-07-15
HUP0203593A2 (hu) 2003-02-28
ES2243332T3 (es) 2005-12-01
CN1377341A (zh) 2002-10-30
DE60021109D1 (de) 2005-08-04
BR0016223A (pt) 2002-09-10
SK286776B6 (sk) 2009-05-07
ZA200204420B (en) 2003-09-03
DE60021109T2 (de) 2006-05-04
CA2393518A1 (en) 2001-06-14
KR20020063205A (ko) 2002-08-01
SK7872002A3 (en) 2002-11-06
US20010018450A1 (en) 2001-08-30
NO20022654D0 (no) 2002-06-05
EP1237866A1 (en) 2002-09-11
JP2003516389A (ja) 2003-05-13
CN1217929C (zh) 2005-09-07
HU225194B1 (en) 2006-08-28
AU781398B2 (en) 2005-05-19
YU13102A (sh) 2005-06-10
CZ20021891A3 (cs) 2002-08-14
MEP28508A (en) 2010-10-10
HRP20020497B1 (en) 2006-04-30
US6642391B2 (en) 2003-11-04
NO20022654L (no) 2002-06-05
SI1237866T1 (en) 2005-10-31
IL149904A (en) 2007-10-31
HK1048998A1 (en) 2003-04-25
RS50288B (sr) 2009-09-08
HRP20020497A2 (en) 2004-08-31

Similar Documents

Publication Publication Date Title
AU635758B2 (en) Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
AU1025795A (en) Prolineamide derivatives
CA2030433A1 (en) New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases
AU692090B2 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
AU3945589A (en) Substituted 4-piperidinyl-indol-5-yl-alkyl-sulphonamide derivatives
AU7001996A (en) Novel derivatives of cyclodepsipeptide PF1022 substance
FI101227B1 (fi) Menetelmä farmaseuttisesti aktiivisten 4-desoksi-4-epipodofyllotoksiinijohdannaisten valmistamiseksi
EE05219B1 (et) Amkomtsiin, meetod selle valmistamiseks, kasutamine ravimina ja seda sisaldav farmatseutiline kompositsioon
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
PT927722E (pt) Derivados beta beta-dissubstituidos de 9-desoxo-9a-n-etenil-9a-aza-9aza-9a-homoeritromicina
PL322862A1 (en) Novel compounds 9-n-ethenylic derivtives of 9(s)-erythromycilamine
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.
GB8803426D0 (en) New compound wf 11605

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20171125